COVID-19 mizaw lakhruak in thlop nakding ah Remdesivir sii hman ding President Trump nih nawl a pek cang
American Food and Drug Administration (FDA) cu COVID-19 mizaw hna thlo
p nakding ah Gilead Sciences Company sii Remdesivir hmannak nawlpek an si cang, tiah President Trump nih May 1 ah a thanh.
Hi sii hi COVID-19 mizaw kha lakhruak in thlopnak ah an hman mi sii a si. White House ah Preisident Trump le Gilead Sciences Company CEO Daniel O’Day tonbiaruahnak an ngeih hnu ah fehter a si i sii zong dur fa mi nuai 1.5 tiang kan hluut lai, tiah O’Day nih a chim.
Hi sii hi FDA nih lakhruak mizaw thlop nakding lawnglawng ah hman lai. Gilead Company nih hin tuan deuh zong ah mizaw 140,000 thlop nakding sii ready a si. Sii-inn tampi ah phawtzamh a si lai i, cucu American Cozah nih a zohfel lai, tiah a thanh. (Ref: DVB)
